RxDoctor Payments Data

Lindsay Cloutier, NP

Primary Care · Morgan City, LANPI 1356702856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,073 and has fallen 85.5% since, to $301 in 2025. Among primary care clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,906in general payments, 2019–2025

Across 234 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$509
  • Novo Nordisk$328
  • Lilly USA, LLC$226
  • GSK$219
  • Astellas Pharma US Inc$210
  • Merck$182
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$3,82198%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,906 in reported general payments places this provider in the 90th percentile of 106 primary care providers in Louisiana.

See all primary care providers in Louisiana

Medicare billing

Part B allowed, 2024
$29,290
Medicare patients
96
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl19$845
Albuterol Sulfate HfaAlbuterol Sulfate19$407
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst34$367
Ciprofloxacin Hcl50$312
Azithromycin62$272
Mupirocin23$246
Levothyroxine Sodium22$212
Escitalopram Oxalate15$193
Potassium Chloride11$172
Pantoprazole Sodium28$129
Fluticasone Propionate11$114
Fluconazole15$100
Cephalexin13$99
Buspirone Hcl15$90
Allopurinol13$85

Paid to pharmacies, not to this prescriber.

Other primary care in Morgan City

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →